-

Canadian Biotech Industry Recognizes Top Performers

Gold Leaf Awards Celebrate the Best in Canadian Biotech

OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada is pleased to announce the 2022 winners in four BIOTECanada Gold Leaf Award categories- Established Biotech Company of the Year, Game Changing Industry Leadership, Ecosystem Builder, and Promising Health Biotech Company of the Year.

  • Established Biotech Company of the Year - AbCellera
  • Game Changing Industry Leadership - Dr. Thomas Madden, President & CEO, Acuitas Therapeutics Inc
  • Ecosystem Builder - adMare BioInnovations
  • Promising Health Biotech Company of the Year - Inversago Pharma

The Gold Leaf Awards celebrate innovation and entrepreneurship within the Canadian biotech industry across all industry categories including health, agricultural, industrial and environmental biotechnology.

“Canadian biotech companies have truly taken to the stage over the past year as demonstrated by their growth and the global recognition of their technologies and innovations. This year’s Gold Leaf award winners are representative of a larger group of phenomenal companies whose teams are driving Canadian innovation and solutions into the global market to help heal, fuel, and grow. All Canadians should be both proud and encouraged by the innovations coming from Canada’s biotech ecosystem which we celebrate through these awards," commented Andrew Casey, President, and CEO BIOTECanada.

The Gold Leaf Awards will be presented during a ceremony at BIONATION in Ottawa Wednesday September 28, 2022.

BIOTECanada is the national industry association and voice with over 240 members of the biotechnology ecosystem located nationwide, reflecting the diverse nature of Canada’s health, industrial and agricultural biotechnology sectors. With unprecedented global issues including the climate crisis, food sustainability and human health needs, the biotechnology industry can play a pivotal role in solving challenges while delivering significant economic benefits, including investment and employment.

Contacts

For more information:
Nadine Lunt
613-793-6338
Nadine.lunt@biotech.ca

BIOTECanada


Release Versions

Contacts

For more information:
Nadine Lunt
613-793-6338
Nadine.lunt@biotech.ca

More News From BIOTECanada

BIOTECanada: Federal Budget Builds on Momentum for Canada’s Life Sciences Sector

OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada welcomes measures in Budget 2026 that can help strengthen Canada’s life sciences sector, including expanded support for research and development, new investment incentives and additional funding for strategic sectors, including biomanufacturing. “Expanding SR&ED eligibility to include certain regulatory approval and intellectual property costs is an important step for biotechnology companies,” said Wendy Zatylny, President and CEO of BIOTECanada...

BIONATION 2026 Makes the Case for Canadian Biotech as a National Priority

OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada concluded BIONATION 2026 this week at the National Arts Centre in Ottawa, convening senior biotechnology and life sciences leaders with policymakers, elected officials, investors, researchers, and partners for two days of discussion on the sector’s strategic role in Canada’s economy, health security, and competitiveness. This year’s program focused on what it takes for Canadian biotechnology companies to grow from Canada, compete globally, and bring...

INSERTING and REPLACING BIONATION 2026 to Bring Canada’s Life Sciences Sector Together in Ottawa

OTTAWA, Ontario--(BUSINESS WIRE)--Inserting events under Tuesday, September 22 and Wednesday, September 23 in media advisory dated September 16, 2026. The updated release reads: BIONATION 2026 TO BRING CANADA’S LIFE SCIENCES SECTOR TOGETHER IN OTTAWA BIOTECanada will host BIONATION at the National Arts Centre in Ottawa, bringing together some 160 biotechnology and life sciences leaders, policymakers, elected officials, investors, researchers, and sector partners for two days of discussion on th...
Back to Newsroom